SCHEMBL845191

SCHEMBL845191

O=C(Cc1cccnc1)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3cccnc3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.52
HTR1A P08908 1/20 0.45
DRD2 P14416 1/20 0.45
CRACR2A Q9BSW2 1/20 0.44
ALDH1A1 P00352 1/20 0.43
PDE3B Q13370 1/20 0.43
TRPV1 Q8NER1 1/20 0.43
HSD11B1 P28845 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
PAX8 Q06710 1/20 0.42
ROCK2 O75116 1/20 0.42
FKBP1A P62942 1/20 0.42
PSMB8 P28062 1/20 0.41
HCRTR1 O43613 2/20 0.41
HCRTR2 O43614 2/20 0.41
VNN1 O95497 1/20 0.41
ACE P12821 1/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
NAMPT P43490 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845712 0.97 HRH3 (0.50) HRH3HTR1ADRD2CRACR2AALDH1A1
SCHEMBL845534 0.92 HRH3 (0.43) HRH3ALDH1A1TRPV1PAX8FKBP1A
SCHEMBL845401 0.92 ALDH1A1 (0.45) HRH3ALDH1A1TRPV1PAX8FKBP1A
SCHEMBL845160 0.88 HSD11B1 (0.53) ALDH1A1HSD11B1HCRTR1HCRTR2KDM4E
SCHEMBL845015 0.86 ALDH1A1 (0.42) HRH3ALDH1A1PAX8FKBP1AHCRTR1
SCHEMBL15116902 0.85 VNN1 (0.44) ALDH1A1PAX8FKBP1AVNN1ACE
SCHEMBL16359563 0.85 VNN1 (0.44) ALDH1A1PAX8FKBP1AVNN1ACE
SCHEMBL845723 0.85 ALDH1A1 (0.51) ALDH1A1FKBP1AHCRTR1HCRTR2KDM4E
SCHEMBL18887502 0.85 HIF1A (0.48) HRH3ALDH1A1TRPV1PAX8FKBP1A
SCHEMBL845375 0.84 MAPK1 (0.46) ALDH1A1ROCK2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed